Nagasaka Hironori, Inoue Ikuo, Inui Ayano, Komatsu Haruki, Sogo Tsuyoshi, Murayama Kei, Murakami Tomoko, Yorifuji Tohru, Asayama Kotaro, Katayama Shigeo, Uemoto Shinji, Kobayashi Kunihiko, Takayanagi Masaki, Fujisawa Tomoo, Tsukahara Hirokazu
Division of Metabolism, Chiba Children's Hospital, Chiba 266-0007, Japan.
Pediatr Res. 2006 Oct;60(4):472-7. doi: 10.1203/01.pdr.0000238341.12229.d3. Epub 2006 Aug 28.
The role of oxidative stress in the pathogenesis of liver disease in Wilson disease (WD), a genetic disorder characterized by excess hepatic deposition of copper that generates free radicals, remains unclear. This study investigates oxidative stress on the liver and hepatic antioxidant responses in WD using liver specimens from affected patients showing mild liver damage (group I, n = 3), moderate or greater liver damage (group II, n = 5), and fulminant hepatic failure (group III, n = 5) and from asymptomatic carriers (n = 2). Decreased ratios of reduced glutathione (GSH) to oxidized glutathione (GSSG) and increased thiobarbituric acid reactive substance (TBARS), a lipid peroxidation product, were found in every affected patient, especially in group II and III patients. Activities and protein expressions of Mn-dependent superoxide dismutase (Mn-SOD), CuZn-dependent superoxide dismutase (CuZn-SOD), and catalase were decreased in all patients, especially in group III patients. Glutathione peroxidase (GPx) activity was decreased only in group III patients. Asymptomatic carriers without any clinical manifestations showed normal TBARS level and GSH/GSSG ratio with increases in both GSH and GSSG levels. Their CuZn-SOD, Mn-SOD, and catalase activities were increased. These results suggest that excessive copper-derived oxidants contribute to development and progression of liver disease in WD.
氧化应激在威尔逊病(WD)肝病发病机制中的作用尚不清楚,WD是一种遗传性疾病,其特征是肝脏中铜过量沉积并产生自由基。本研究使用来自轻度肝损伤患者(I组,n = 3)、中度或更严重肝损伤患者(II组,n = 5)、暴发性肝衰竭患者(III组,n = 5)以及无症状携带者(n = 2)的肝脏标本,研究了WD患者肝脏的氧化应激和肝脏抗氧化反应。在每例受影响患者中均发现还原型谷胱甘肽(GSH)与氧化型谷胱甘肽(GSSG)的比率降低,以及脂质过氧化产物硫代巴比妥酸反应性物质(TBARS)增加,尤其是在II组和III组患者中。所有患者中锰依赖性超氧化物歧化酶(Mn-SOD)、铜锌依赖性超氧化物歧化酶(CuZn-SOD)和过氧化氢酶的活性及蛋白表达均降低,尤其是III组患者。谷胱甘肽过氧化物酶(GPx)活性仅在III组患者中降低。无任何临床表现的无症状携带者的TBARS水平和GSH/GSSG比率正常,GSH和GSSG水平均升高。他们的CuZn-SOD、Mn-SOD和过氧化氢酶活性增加。这些结果表明,过量的铜衍生氧化剂促成了WD患者肝病的发生和发展。